KR101060331B1 - 인플루엔자 바이러스 감염의 치료에 유용한 약제의 제조를위한 레스베라트롤의 용도 - Google Patents
인플루엔자 바이러스 감염의 치료에 유용한 약제의 제조를위한 레스베라트롤의 용도 Download PDFInfo
- Publication number
- KR101060331B1 KR101060331B1 KR1020057007230A KR20057007230A KR101060331B1 KR 101060331 B1 KR101060331 B1 KR 101060331B1 KR 1020057007230 A KR1020057007230 A KR 1020057007230A KR 20057007230 A KR20057007230 A KR 20057007230A KR 101060331 B1 KR101060331 B1 KR 101060331B1
- Authority
- KR
- South Korea
- Prior art keywords
- resveratrol
- virus
- cells
- infection
- influenza virus
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (3)
- 유효 성분으로서 레스베라트롤을 포함하고, 인플루엔자 바이러스 복제를 억제하여 인플루엔자 바이러스 감염의 치료에 유용한 약학 조성물.
- 제 1 항에 있어서, 바이러스가 인간 인플루엔자 바이러스인 약학 조성물.
- 제 1 항에 있어서, 수의학 분야에서 바이러스 감염의 치료에 유용한 약학 조성물.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITRM2002A000562 | 2002-11-06 | ||
IT000562A ITRM20020562A1 (it) | 2002-11-06 | 2002-11-06 | Uso del resveratrolo per la preparazione di un medicamento utile per il trattamento delle infezioni da virus dell'influenza. |
PCT/IT2003/000626 WO2004041260A1 (en) | 2002-11-06 | 2003-10-14 | Use of resveratrol for the preparation of a medicament useful for the treatment of influenza virus infections |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20050071627A KR20050071627A (ko) | 2005-07-07 |
KR101060331B1 true KR101060331B1 (ko) | 2011-08-30 |
Family
ID=32310188
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020057007230A KR101060331B1 (ko) | 2002-11-06 | 2003-10-14 | 인플루엔자 바이러스 감염의 치료에 유용한 약제의 제조를위한 레스베라트롤의 용도 |
Country Status (18)
Country | Link |
---|---|
US (1) | US8431617B2 (ko) |
EP (1) | EP1567137B1 (ko) |
JP (1) | JP4589118B2 (ko) |
KR (1) | KR101060331B1 (ko) |
AR (1) | AR041891A1 (ko) |
AT (1) | ATE381929T1 (ko) |
AU (1) | AU2003279551A1 (ko) |
CA (1) | CA2504872C (ko) |
CY (1) | CY1107302T1 (ko) |
DE (1) | DE60318327T2 (ko) |
DK (1) | DK1567137T3 (ko) |
ES (1) | ES2295660T3 (ko) |
IT (1) | ITRM20020562A1 (ko) |
MX (1) | MXPA05004628A (ko) |
PL (1) | PL217628B1 (ko) |
PT (1) | PT1567137E (ko) |
TW (1) | TWI337863B (ko) |
WO (1) | WO2004041260A1 (ko) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080260690A1 (en) * | 2005-11-18 | 2008-10-23 | Ares Trading S.A. | Interferon in Influenza |
CA2717119A1 (en) * | 2008-03-06 | 2009-11-12 | Mount Sinai School Of Medicine Of New York University | Compounds that modulate negative-sense, single-stranded rna virus replication and uses thereof |
US20100112099A1 (en) * | 2008-11-04 | 2010-05-06 | Metaproteomics, Llc | Phytochemical compositions and methods for activating amp-kinase |
EP2373329A4 (en) * | 2008-12-19 | 2012-07-04 | Univ California | USE OF INGREDIENTS OF THE EPIDERMAL GROWTH FACTOR IN THE TREATMENT OF VIRUS INFECTIONS |
KR100950445B1 (ko) | 2009-10-26 | 2010-04-02 | 주식회사 중앙백신연구소 | 감초로부터 얻은 조류, 돼지 인플루엔자 및 신종플루에 대한 항바이러스제 |
WO2011150413A1 (en) | 2010-05-28 | 2011-12-01 | Mount Sinai School Of Medicine | Antiviral compounds and uses thereof |
CA2850597A1 (en) * | 2011-09-30 | 2013-04-04 | Vanderbilt University | Antiviral therapies with phospholipase d inhibitors |
EP2952180B1 (en) | 2014-06-04 | 2017-01-25 | SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. | Solid formulations containing resveratrol and omega-3 polyunsaturated fatty acids (n-3 PUFA) |
PL2952209T3 (pl) | 2014-06-04 | 2018-07-31 | Alfasigma S P A | Jednorodne formulacje zawierające wielonienasycone kwasy tłuszczowe omega-3 (n-3 PUFA) i resweratrol do podawania doustnego |
EP3120842A1 (en) * | 2015-07-20 | 2017-01-25 | Opterion Health AG | Peritoneal therapeutic fluid |
KR20170039456A (ko) | 2015-10-01 | 2017-04-11 | 동아대학교 산학협력단 | 오동나무로부터 추출한 c-제라닐플라보노이드계 물질을 포함하는 인플루엔자 예방 및 치료용 약학 조성물 |
JP2018024592A (ja) * | 2016-08-09 | 2018-02-15 | 株式会社ブレインヘルス | 抗生物質含有組成物 |
CN108893558B (zh) * | 2018-05-24 | 2022-04-05 | 江苏海宏制药有限公司 | 一种桑木液原液抗病毒实验方法以及装置 |
WO2021207094A1 (en) * | 2020-04-05 | 2021-10-14 | Mong Michael | Systems and methods for treating coronavirus |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001008671A2 (en) * | 1999-07-30 | 2001-02-08 | The Procter & Gamble Company | Method and composition for prophylaxis and treatment of symptoms associated with cold and influenza-like illnesses |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2778337B1 (fr) * | 1998-05-05 | 2001-08-31 | Inst Nat Sante Rech Med | Antagonistes des ligands du recepteur des arylhydrocarbures |
US6479466B1 (en) * | 1999-08-13 | 2002-11-12 | University Of Maryland | Compositions for treating viral infections, and methods therefor |
-
2002
- 2002-11-06 IT IT000562A patent/ITRM20020562A1/it unknown
-
2003
- 2003-10-14 AT AT03772659T patent/ATE381929T1/de active
- 2003-10-14 EP EP03772659A patent/EP1567137B1/en not_active Expired - Lifetime
- 2003-10-14 CA CA2504872A patent/CA2504872C/en not_active Expired - Lifetime
- 2003-10-14 KR KR1020057007230A patent/KR101060331B1/ko active IP Right Grant
- 2003-10-14 ES ES03772659T patent/ES2295660T3/es not_active Expired - Lifetime
- 2003-10-14 DK DK03772659T patent/DK1567137T3/da active
- 2003-10-14 JP JP2004549541A patent/JP4589118B2/ja not_active Expired - Lifetime
- 2003-10-14 AU AU2003279551A patent/AU2003279551A1/en not_active Abandoned
- 2003-10-14 MX MXPA05004628A patent/MXPA05004628A/es active IP Right Grant
- 2003-10-14 PT PT03772659T patent/PT1567137E/pt unknown
- 2003-10-14 PL PL377557A patent/PL217628B1/pl unknown
- 2003-10-14 DE DE60318327T patent/DE60318327T2/de not_active Expired - Lifetime
- 2003-10-14 US US10/533,942 patent/US8431617B2/en active Active
- 2003-10-14 WO PCT/IT2003/000626 patent/WO2004041260A1/en active IP Right Grant
- 2003-10-27 TW TW092129780A patent/TWI337863B/zh not_active IP Right Cessation
- 2003-11-05 AR ARP030104047A patent/AR041891A1/es unknown
-
2008
- 2008-03-12 CY CY20081100281T patent/CY1107302T1/el unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001008671A2 (en) * | 1999-07-30 | 2001-02-08 | The Procter & Gamble Company | Method and composition for prophylaxis and treatment of symptoms associated with cold and influenza-like illnesses |
Also Published As
Publication number | Publication date |
---|---|
WO2004041260A1 (en) | 2004-05-21 |
AU2003279551A1 (en) | 2004-06-07 |
CY1107302T1 (el) | 2012-11-21 |
ES2295660T3 (es) | 2008-04-16 |
DK1567137T3 (da) | 2008-04-28 |
KR20050071627A (ko) | 2005-07-07 |
US20050239906A1 (en) | 2005-10-27 |
TWI337863B (en) | 2011-03-01 |
DE60318327T2 (de) | 2008-12-18 |
DE60318327D1 (de) | 2008-02-07 |
CA2504872A1 (en) | 2004-05-21 |
EP1567137B1 (en) | 2007-12-26 |
TW200501935A (en) | 2005-01-16 |
CA2504872C (en) | 2011-07-05 |
ITRM20020562A1 (it) | 2004-05-07 |
JP2006507295A (ja) | 2006-03-02 |
EP1567137A1 (en) | 2005-08-31 |
PL217628B1 (pl) | 2014-08-29 |
ATE381929T1 (de) | 2008-01-15 |
AR041891A1 (es) | 2005-06-01 |
US8431617B2 (en) | 2013-04-30 |
MXPA05004628A (es) | 2005-09-08 |
PL377557A1 (pl) | 2006-02-06 |
JP4589118B2 (ja) | 2010-12-01 |
PT1567137E (pt) | 2008-02-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Yan et al. | Luteolin decreases the yield of influenza A virus in vitro by interfering with the coat protein I complex expression | |
Zhao et al. | A broad-spectrum virus-and host-targeting peptide against respiratory viruses including influenza virus and SARS-CoV-2 | |
KR101060331B1 (ko) | 인플루엔자 바이러스 감염의 치료에 유용한 약제의 제조를위한 레스베라트롤의 용도 | |
Amatore et al. | Influenza virus replication in lung epithelial cells depends on redox‐sensitive pathways activated by NOX4‐derived ROS | |
Isaacs et al. | Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus | |
Shin et al. | Broad‐spectrum antiviral effect of Agrimonia pilosa extract on influenza viruses | |
Jeong et al. | Identification of regulators of the early stage of viral hemorrhagic septicemia virus infection during curcumin treatment | |
Xu et al. | Inhibition of peptide BF-30 on influenza A virus infection in vitro/vivo by causing virion membrane fusion | |
Li et al. | Glutamine starvation inhibits snakehead vesiculovirus replication via inducing autophagy associated with the disturbance of endogenous glutathione pool | |
US20220241325A1 (en) | Antioxidant and antiviral compositions and methods | |
Guo et al. | Axin1: a novel scaffold protein joins the antiviral network of interferon | |
Liu et al. | The dual role of HIV-1 gp120 V3 loop-induced autophagy in the survival and apoptosis of the primary rat hippocampal neurons | |
Zhao et al. | A broad-spectrum virus-and host-targeting antiviral peptide against SARS-CoV-2 and other respiratory viruses | |
KR20200026390A (ko) | 이오노포어를 유효성분으로 포함하는 바이러스성 질환의 예방 또는 치료용 보조제 | |
WO2021229602A1 (en) | Use of compounds for treating viral infections | |
Marquez et al. | Broad-Spectrum Antiviral Effect of Cannabidiol Against Enveloped and Nonenveloped Viruses | |
US20200230115A1 (en) | Methods of treating influenza-associated viral pneumonia | |
Kirkpatrick et al. | Inducible lung epithelial resistance requires multisource reactive oxygen species generation to protect against viral infections. mBio 9: e00696-18 | |
Liu et al. | Infectious Bronchitis Virus Triggered Caspase-8/Casapase-3/DFNA5-Mediated Pyroptosis in HD11 Cells Via ROS | |
US20220401554A1 (en) | Use of membrane inhibitors to enhance vaccine development against enveloped viruses | |
Zhou et al. | Phenolic compound SG-1 from Balanophora harlandii and its derivatives exert anti-influenza A virus activity via activation of the Nrf2/HO-1 pathway | |
KR102434383B1 (ko) | 매스틱 검을 유효성분으로 함유하는 항바이러스 조성물 | |
Kathum | Reduction of some viral protein's gene expression of recombinant influenza A/H1N1-PR8 virus upon treatment with Punica granatum crude extract | |
Cheang | Biological screening for anti-influenza a virus agents | |
Tan | Biological screening for anti-influenza a virus agents/Tan Ming Cheang |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20140806 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20150806 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20160809 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20170810 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20180809 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20190808 Year of fee payment: 9 |